Pharmafile Logo
Pharmafocus logo
Advanced Search

Insider Interview: Reducing the risk of adverse cardiovascular events

February 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma

Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …

Feature
gilead-sciences

Gilead’s experimental Ebola drug being tested in patients infected with coronavirus

February 3, 2020
Sales and Marketing Coronavirus Wuhan, MERS, Sars, Wuhan, coronavirus, coronavirus China

China and the US are testing Gilead’s remdesivir in patients with the coronavirus, in the hopes of developing an effective …

News
humacao_exterior

BMS pulls Opdivo+Yervoy combo in EU for advanced non-small cell lung cancer

February 3, 2020
Sales and Marketing BMS, Cancer, Europe, Yervoy, lung cancer, opdivo

Bristol-Myers Squibb has confirmed it has withdrawn its application with the European Commission for its combination of Opdivo (nivolumab) and …

News
mercado_de_mariscos_de_wuhan_cerrado_tras_detectarse_ahi_por_primera_vez_el_nuevo_coronavirus_

More Britons evacuated from Wuhan as UK donates £20 million to speed up vaccine

February 3, 2020
Sales and Marketing China virus, MERS, Sars, Wuhan Coronavirus, coronavirus, coronavirus China

More Britons have been flown back from Wuhan, the heart of the coronavirus outbreak, while the UK government has donated …

News
abbvie_0

AbbVie’s Venclyxto pins down CHMP approval for treatment-naive chronic lymphocytic leukaemia

February 3, 2020
Sales and Marketing AbbVie, CHMP, EMA, Venclyxto, pharma

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has awarded recommendation to AbbVie’s Venclyxto (venetoclax), …

News
15031804271_3791dafae1_b

FDA approves first treatment for peanut allergy

February 3, 2020
Sales and Marketing FDA, FDA Peanuts, peanut, peanut allergy, peanut medicine

The FDA has approved its first treatment for peanut allergy in patients between ages four and 17. The drug is …

News
david_hallett

AI firm Exscientia appoints COO and Head of Drug Discovery

January 31, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exscientia, appointment

AI drug discovery firm Exscientia has announced the appointment of Dr David Hallett as its Chief Operating Officer and Head …

Appointment
512px-gwyneth_paltrow_avp_iron_man_3_paris_2

NHS Chief Simon Stevens: Gwyneth Paltrow’s Goop poses “considerable risks to health”

January 31, 2020
Medical Communications Goop, Gwyneth Platrow, NHS, Simon Stevens, pharma

NHS Chief Executive Simon Stevens has gone head-to-head with Hollywood actor and “wellness guru” Gwyneth Paltrow, taking aim at her …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

January 31, 2020
Medical Communications Janseen, Ketamine, NHS, NICE, Nasal sprays, Nasl, Top 10 of the week, top 10

This week nasal sprays based on illegal recreational drugs feature prominently, as the FDA has moved to approve Lannett Company’s …

News
citizens_of_wuhan_lining_up_outside_of_a_drug_store_to_buy_masks_during_the_wuhan_coronavirus_outbreak

Two coronavirus cases in the UK as WHO declare outbreak as a ‘global emergency’

January 31, 2020
Medical Communications Chinese Coronavirus, MERS, Wuhan Coronavirus, coronavirus, sara

Two people have tested positive for the Wuhan coronavirus in the UK, they are both part of the same family …

News
shutterstock_159488225

Bayer and Orion’s Nubeqa shows off strong overall survival benefit in castration-resistant prostate cancer

January 31, 2020
Medical Communications, Research and Development Bayer, orion, pharma

Bayer and Finnish pharma firm Orion Corporation have announced positive new Phase 3 data for their jointly developed oral androgen …

News
42271822770_6d2a1d533f_b

Exscientia creates first drug using AI

January 31, 2020
Medical Communications AI, AI healthcare, ai pharma

Exscientia has created a new OCD drug using artificial intelligence to sift through potential compounds, checking them against a huge …

News
pharmafocus_janfeb_2020_cover

Read the January/February 2020 edition of Pharmafocus online now!

January 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma

Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …

News
29565810402_e48022a5ca_b

FDA warns Purell not to claim sanitizers prevent Ebola

January 30, 2020
Business Services Ebola, Ebola africa, Ebola vaccine, hand sanitiser

The FDA has issued a warning letter to Purcell telling them to stop its misleading advertising of their sanitiser products. …

News
smoking

Healthy cells in lungs can repair the damage from smoking

January 30, 2020
Business Services Cancer smoking, cigarettes, lung cancer, lungs, smoking

Human lungs have the ‘magical’ ability to repair the cancerous mutations caused by smoking cigarettes, but only if people quit …

News
shutterstock_36423250

Spring Bank Pharma shuts down HBV drug development following patient death

January 30, 2020
Research and Development Spring Bank, patient death, pharma

Biopharma firm Spring Bank Pharmaceuticals has revealed it has taken the decision to terminate all further development of inarigivir soproxil …

News

Johnson & Johnson working on coronavirus vaccine

January 30, 2020
Business Services, Research and Development Chinese Coronavirus, Wuhan Coronavirus, Wuhan epidemic, coronavirus

Johnson & Johnson has become the latest pharmaceutical company to begin work on a vaccine for the Chinese coronavirus. They …

News
logo-24-allergan

Allergan opens new Botox plant in Westport

January 29, 2020
Research and Development AbbVie Ireland, Allergan AbbVie, Allergan. Abbvie

Allergan has officially opened a new €145m facility in Westport, Ireland to boost production of Botox. The new building rxpands …

News
janssen_latest_logo_on_sign_closer

Janssen’s Erleada expanded in Europe to cover metastatic hormone-sensitive prostate cancer

January 29, 2020
Research and Development, Sales and Marketing Erleada, Europe, Janssen, pharma

Janssen’s Erleada (apalutamide) has secured expanded authorisation from the European Commission (EC), approving its label to include the treatment of …

News

BioIntelliSense’ BioSticker sensor approved by the FDA

January 29, 2020
Research and Development Biosticker, home care, sensors

BioIntelliSense has secured 510 (k) clearance from the FDA for its biosticker sensor for remote care. The product is an …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025